Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

newsroom.regeneron.com

Regeneron Pharmaceuticals Inc. News Releases

Get the latest updates from Regeneron Pharmaceuticals Inc. News Releases directly as they happen.

Follow now 135 followers

Latest posts

Last updated 6 days ago

Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma

6 days ago

TARRYTOWN, N.Y. , July 02, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025

12 days ago

TARRYTOWN, N.Y. , June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...

Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization

14 days ago

Initiative aims to expand and encourage philanthropy to help patients with retinal...

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

19 days ago

Approval based on pivotal results showing improvements in sustained disease remission and...

Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color

about 1 month ago

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color...

Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist

about 1 month ago

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP...

Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials

about 1 month ago

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in...